
September 27, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kenneth Frazier, MSD, pharma

September 27, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hurricane Florence, NHS, Pharmafocus, US, biosimilars, market access, mental health, pharma

September 26, 2018 Research and Development Alexion, neuromyelitis optica spectrum disorder, pharma, rare disease, soliris

September 26, 2018 Research and Development Alunbrig, R&D, Takeda, phase III, research

September 26, 2018 Research and Development Cancer, Combo, Roche, chemotherapy, lung cancer, pharma, tecentriq

September 26, 2018 Research and Development Scotland, UK, health, life expectancy, uk politics

September 25, 2018 Business Services, Research and Development

September 25, 2018 Research and Development CAR T, CAR-T, Cancer, Duff and Phelps, Kymriah, access, oncology, pricing

September 25, 2018 Manufacturing and Production, Research and Development, Sales and Marketing Cancer, NSCLC, NSCLC< lung cancer, Roche, entrectinib

September 24, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing UCB, Working Life, feature

September 24, 2018 Research and Development, Sales and Marketing CHMP, Duchenne Muscular Dystophy, EMA, Europe, Exondys 51, pharma, sarepta

September 24, 2018 Research and Development, Sales and Marketing AstraZeneca, diabetes, farxiga, pharma

September 21, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Jobs, Novartis, Novo Nordisk, Senate, UCB, manufacturing, opioid crisis, top 10

September 20, 2018 Business Services, Research and Development Molecular Templates, Shares, Takeda, markets, stocks

September 20, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, Roche, pharma